The Long Run with Luke Timmerman · March 3 · 1 hr 5 min
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
0:00-1:05:45
transcript
show notes
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
